VaramirStart free · no cardSign in
IRWD as of Nov 1 · 02:09 ET
IRWDNasdaqPharmaceutical Preparations

Ironwood Pharmaceuticals Inc · Brief

Next report

8 days

Nov 9 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±30.8%
avg realized
±13.9%
Apr 25 '25±57.8%▲+1.12%×0.02
May 7 '25±47.7%▼−14.55%×0.31
Aug 7 '25±35.6%▲+9.32%×0.26
Q3 FY25±27.6%▲+31.77%×1.15
Jan 2 '26±28.3%▲+26.71%×0.94
Q1 FY26±22.4%▼−11.35%×0.51
May 7 '26±11.8%▼−13.66%×1.16
Q2 FY26±15.6%▲+2.65%×0.17
quarterimplied−60%0+60%realized×
Q2 FY26±15.6%▲+2.65%×0.17
May '26±11.8%▼−13.66%×1.16
Q1 FY26±22.4%▼−11.35%×0.51
Jan '26±28.3%▲+26.71%×0.94
Q3 FY25±27.6%▲+31.77%×1.15
Aug '25±35.6%▲+9.32%×0.26
2 older reports
May '25±47.7%▼−14.55%×0.31
Apr '25±57.8%▲+1.12%×0.02
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

9disclosed supplier and customer ties in SEC filingsSEC filings
212managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

6 of 8recent reports where the move came in under the options implied rangeEarnings history
11 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

IRWD report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±33.4% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.